Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Liebertz

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2010
Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cellsMelissa G Lechner, Daniel J Liebertz, Alan L Epstein
Birth Defects Research. Part C, Embryo Today : Reviews|December 16, 2014
Cleft palate: a clinical reviewMahdi A Shkoukani, Lauren A Lawrence, Daniel J Liebertz, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|May 15, 2015
Impact of Postreconstitution Room Temperature Storage on the Efficacy of IncobotulinumtoxinA Treatment of Dynamic Lateral Canthus LinesDanny J Soares, Louis M Dejoseph, Giancarlo F Zuliani, et al.
Cancer|March 23, 2011
Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entityMelissa G Lechner, Stephen Lade, Daniel J Liebertz, et al.
Head & Neck Oncology|February 24, 2010
Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1Daniel J Liebertz, Melissa G Lechner, Rizwan Masood, et al.
Oral Oncology|July 2, 2011
USC-HN2, a new model cell line for recurrent oral cavity squamous cell carcinoma with immunosuppressive characteristicsSarah M Russell, Melissa G Lechner, Lucy Gong, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2010
Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cellsMelissa G Lechner, Daniel J Liebertz, Alan L Epstein
Birth Defects Research. Part C, Embryo Today : Reviews|December 16, 2014
Cleft palate: a clinical reviewMahdi A Shkoukani, Lauren A Lawrence, Daniel J Liebertz, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|May 15, 2015
Impact of Postreconstitution Room Temperature Storage on the Efficacy of IncobotulinumtoxinA Treatment of Dynamic Lateral Canthus LinesDanny J Soares, Louis M Dejoseph, Giancarlo F Zuliani, et al.
Cancer|March 23, 2011
Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entityMelissa G Lechner, Stephen Lade, Daniel J Liebertz, et al.
Head & Neck Oncology|February 24, 2010
Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1Daniel J Liebertz, Melissa G Lechner, Rizwan Masood, et al.
Oral Oncology|July 2, 2011
USC-HN2, a new model cell line for recurrent oral cavity squamous cell carcinoma with immunosuppressive characteristicsSarah M Russell, Melissa G Lechner, Lucy Gong, et al.
Pageof 1